Skip to main content

Table 2 Results of NLC formulation optimization experiment using a U*7(74) uniform experimental design (mean ± standard deviation, n = 3)

From: Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum

NLCs

Response (Y1)

Response (Y2)

Response (Y3)

Response (Y4)

Response (Y5)

Size (nm)

EE (LA, %)

EE (RAN, %)

DL (LA, %)

DL (RAN, %)

NLC1

374.0 ± 25.7

54.70 ± 7.23

48.93 ± 5.63

0.78 ± 0.05

0.04 ± 0.01

NLC2

137.2 ± 11.3

66.82 ± 2.66

57.78 ± 1.97

1.33 ± 0.12

0.02 ± 0.01

NLC3

353.4 ± 28.5

66.07 ± 8.63

65.27 ± 9.73

2.14 ± 0.11

0.12 ± 0.02

NLC4

508.7 ± 68.7

81.45 ± 5.92

57.46 ± 3.24

6.67 ± 0.58

0.26 ± 0.02

NLC5

424.3 ± 41.2

88.25 ± 7.22

80.84 ± 8.45

8.89 ± 0.57

0.85 ± 0.02

NLC6

157.9 ± 20.3

93.14 ± 6.12

83.86 ± 7.23

13.58 ± 1.21

1.59 ± 0.09

NLC7

97.1 ± 11.2

71.31 ± 4.32

78.85 ± 6.11

1.91 ± 0.22

0.21 ± 0.02